newsfilter
← Latest News
Bloomberg·

Valeant Drop Ripples Through Drug Stocks

A $20 billion selloff in Valeant Pharmaceuticals International Inc. spurred a battering in drug stocks seen as sharing its taste for acquisitions, sending Mallinckrodt Plc and Endo International Plc tumbling.